Anwer S
ORCID: 0000-0002-1740-0399
· 1 paper in corpus
BackgroundMulti-indication cancer drugs receive licensing extensions to include additional indications, as trial evidence on treatment effectiveness accumulates. We investigate how sharing information across indications can strengthen the i…